Sponsored by:

Molecular Imaging: Page 428

IBA, Lantheus ink radiopharma deal
By AuntMinnie.com staff writers
Belgian radiopharmaceutical firm Ion Beam Applications (IBA) has signed an exclusive distribution deal with Lantheus Medical Imaging.
July 30, 2008
SPECT/CT mammography system produces first patient images
By Kathlyn Stone
HOUSTON - Duke University researchers have begun the first patient studies of a hybrid SPECT/CT mammography system, and the unit has several advantages over conventional breast imaging technology, according to their findings.
July 29, 2008
2008 07 30 09 38 17 42 Madhav Duke Aapm2008 Hybrid Patient Thumb
Alliance buys mobile PET/CT firm
By AuntMinnie.com staff writers
Imaging services provider Alliance Imaging has acquired a mobile PET/CT firm based in Illinois.
July 29, 2008
GE touts PET agent clinical results
By AuntMinnie.com staff writers
GE Healthcare is touting promising results from a phase I clinical trial of GE-067, a fluorine-18-labeled PET imaging agent being developed to assist in the detection of brain beta-amyloid.
July 28, 2008
Digirad posts loss in Q2
By AuntMinnie.com staff writers
A 5.8% increase in second-quarter revenue wasn't enough to bring profitability to nuclear medicine vendor Digirad.
July 28, 2008
NST is cleared for ApoSense trials
By AuntMinnie.com staff writers
NeuroSurvival Technologies (NST) has received the go-ahead from the U.S. Food and Drug Administration to begin clinical trials of ApoSense.
July 24, 2008
GE gets FDA nod for new PET/CT system
By AuntMinnie.com staff writers
GE Healthcare has received U.S. Food and Drug Administration clearance for a new PET/CT scanner.
July 23, 2008
FluoroPharma touts phase I tracer trial
By AuntMinnie.com staff writers
Imaging agent developer FluoroPharma has received positive phase I clinical trial results for its myocardial perfusion imaging tracer.
July 22, 2008
SNM draft report shows U.S. Mo-99 production years away
By Wayne Forrest
There are no quick fixes to the manufacture of medical radioisotopes in the U.S. to ensure an adequate supply of molybdenum-99 (Mo-99) in the future. A preliminary draft report has found that U.S. production and supply of Mo-99 is several years away and would require significant investment and regulatory approvals.
July 21, 2008
Cannavo on the future of PACS; SNM on isotope crisis
By Brian Casey
July 21, 2008
Eczacıbaşı Pharmaceuticals buys half of Monrol
By AuntMinnie.com staff writers
Eczacıbaşı Pharmaceuticals Manufacturing of Istanbul has acquired half of Monrol Nuclear Products of Kocaeli, Turkey.
July 17, 2008
MDS plans restructuring
By AuntMinnie.com staff writers
Canadian healthcare company MDS is restructuring in an effort to increase profitability at MDS Pharma Services and MDS Analytical Technologies.
July 17, 2008
Previous Page
Page 428 of 612
Next Page